Temasek Holdings has led a $70 million Series C round for Chinese drug developer Abbisko Therapeutics.
Several existing investors participated, including Qiming Venture Partners, Lilly Asia Ventures, CICC Capital, Loyal Valley Capital, Jianxin Capital, and GIC Private. It follows a $42 million Series B...
KKR has offered to acquire up to 9% of First Gen Corporation, a power plant operator in the Philippines, for PHP7.29 billion ($144 million).
Japan’s Beyond Next Ventures has led a JPY800 billion ($7.4 million) Series A round for local cell-based agricultural technology specialist IntegriCulture.
Chinese drug developer Jiangsu Atom Bioscience & Pharmaceutical has raised $30 million in Series B funding led by Sequoia Capital China and Hong Kong-listed Livzon Pharmaceutical Group.
Hillhouse Capital has led an extended Series A round of funding worth $50 million for Deepexi, a Chinese start-up that provides a suite of smart data services to enterprise customers.